Eligi
Med
Ensayos clínicos
Suscripción
Sobre EligiMed
Ensayos Clínicos de Neumología | EligiMed
Ensayos clínicos
8.676 ensayos encontrados
Reclutando
Fase 3
ClinicalTrials.gov
A Randomized, Double-blind Study to Compare the Pharmacokinetics Between ABP 234 and Keytruda® (Pembrolizumab) in Participants With Early-stage Non-squamous Non-small Cell Lung Cancer as Adjuvant Treatment Following Resection and Platinum-based Chemotherapy
INTERVENTIONAL
Inicio: 12 de sept de 2024
ID: NCT06430866
Completado
Fase 3
ClinicalTrials.gov
Long-term Extension, Multicentre, Multi-international Study to Evaluate the Safety and Tolerability of Oral BAY63-2521 (1mg, 1.5 mg, 2.0 mg, 2.5 mg Tid) in Patients With Chronic Thromboembolic Pulmonary Hypertension (CTEPH).
INTERVENTIONAL
Inicio: 1 de jul de 2009
ID: NCT00910429
Completado
Fase 3
ClinicalTrials.gov
A Phase III, International, Randomised, Double Blind, Parallel-Group Study to Assess the Efficacy of Zactima™ Versus Tarceva® in Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer After Failure of at Least One Prior Chemotherapy
INTERVENTIONAL
Inicio: 1 de ago de 2006
ID: NCT00364351
Terminado
Fase 2
ClinicalTrials.gov
A Long-term, Multicenter, Single-arm, Open-label Extension of the SERENADE Study, to Assess the Safety and Efficacy of Macitentan in Subjects With Heart Failure With Preserved Ejection Fraction and Pulmonary Vascular Disease
INTERVENTIONAL
Inicio: 7 de dic de 2018
ID: NCT03714815
Activo, no recluta
Fase 2
ClinicalTrials.gov
A Multi-centre Phase II, Double-Blind, Randomised Study of Savolitinib in Combination With Osimertinib vs Savolitinib in Combination With Placebo in Patients With EGFRm+ and MET Amplified Locally Advanced or Metastatic Non-Small Cell Lung Cancer Who Have Progressed Following Treatment With Osimertinib
INTERVENTIONAL
Inicio: 28 de sept de 2020
ID: NCT04606771
Retirado
Fase 3
ClinicalTrials.gov
A Phase Ib/II Safety Trial of Nivolumab in Combination With Ipilimumab Administered in Participants With Chemotherapy-naive Stage IV or Recurrent Non-small Cell Lung Cancer (NSCLC) (CheckMate 955: CHECKpoint Pathway and nivoluMAb Clinical Trial Evaluation 955)
INTERVENTIONAL
Inicio: 9 de mar de 2018
ID: NCT03048136
Completado
ClinicalTrials.gov
Effects of Pneumoperitoneum on Dynamic Alveolar Stress-strain in Anesthetized Pediatric Patients
OBSERVATIONAL
Inicio: 6 de ene de 2020
ID: NCT04183309
Completado
Fase 3
ClinicalTrials.gov
An Open-label Extension Trial of the Long Term Safety of Nintedanib in Patients With 'Systemic Sclerosis Associated Interstitial Lung Disease' (SSc-ILD)
INTERVENTIONAL
Inicio: 27 de nov de 2017
ID: NCT03313180
Completado
Fase 3
ClinicalTrials.gov
A 12 Week Study to Evaluate the Effect of Fluticasone Furoate (FF, GW685698)/Vilanterol (VI, GW642444) 100/25 mcg Inhalation Powder Delivered Once Daily Via a Novel Dry Powder Inhaler (NDPI) on Arterial Stiffness Compared With Tiotropium Bromide 18 mcg Delivered Once Daily Via a HandiHaler in Subjects With Chronic Obstructive Pulmonary Disease (COPD).
INTERVENTIONAL
Inicio: 30 de jun de 2011
ID: NCT01395888
Terminado
ClinicalTrials.gov
Exhaled Breath Condensate pH in Mechanically Ventilated Patients
OBSERVATIONAL
Inicio: 1 de ago de 2007
ID: NCT01393431
Completado
Fase 3
ClinicalTrials.gov
Extension Study to the Multicenter, Open-label, Randomized, Controlled Study CRAD001H2304 to Evaluate the Long-term Efficacy and Safety of Concentration-controlled Everolimus in Liver Transplant Recipient
INTERVENTIONAL
Inicio: 31 de mar de 2010
ID: NCT01150097
Reclutando
Fase 3
ClinicalTrials.gov
An Open-label Extension Trial of the Long-term Safety and Efficacy of BI 1015550 Taken Orally in Patients With Idiopathic Pulmonary Fibrosis (IPF) and Progressive Pulmonary Fibrosis (PPF) (FIBRONEER™-ON)
INTERVENTIONAL
Inicio: 6 de may de 2024
ID: NCT06238622
Completado
ClinicalTrials.gov
Sonographic Assessment of Postural Lung Recruitment in Pediatric Patients Under General Anesthesia
INTERVENTIONAL
Inicio: 15 de may de 2017
ID: NCT03141515
Completado
Fase 3
ClinicalTrials.gov
Open-label, Interventional, Cohort Study to Evaluate Long-term Safety of Dupilumab in Patients With Moderate to Severe Asthma Who Completed the TRAVERSE-LTS12551 Clinical Trial
INTERVENTIONAL
Inicio: 30 de ago de 2018
ID: NCT03620747
Terminado
Fase 3
ClinicalTrials.gov
A Randomized, Placebo-controlled, Double-blind, Multi-center, Phase III Trial to Assess the Efficacy and Safety of Trimodulin (BT588) in Adult Hospitalized Subjects With CAP Including COVID-19 Pneumonia.
INTERVENTIONAL
Inicio: 22 de dic de 2022
ID: NCT05531149
Completado
Fase 4
ClinicalTrials.gov
A 24-week Treatment, Multi-center, Randomized, Double-blind, Double-dummy, Parallel Group Study to Compare Umeclidinium/Vilanterol, Umeclidinium, and Salmeterol in Subjects With Chronic Obstructive Pulmonary Disease (COPD)
INTERVENTIONAL
Inicio: 16 de jun de 2017
ID: NCT03034915
Completado
Fase 3
ClinicalTrials.gov
A Double Blind, Randomised, Placebo-controlled Trial Evaluating Efficacy and Safety of Oral Nintedanib Treatment for at Least 52 Weeks in Patients With Systemic Sclerosis Associated Interstitial Lung Disease (SSc-ILD)
INTERVENTIONAL
Inicio: 12 de nov de 2015
ID: NCT02597933
Por invitación
Fase 3
ClinicalTrials.gov
An Open-label Extension Study of Inhaled Treprostinil in Subjects With Fibrotic Lung Disease (TETON-OLE)
INTERVENTIONAL
Inicio: 6 de sept de 2022
ID: NCT04905693
Completado
Fase 4
ClinicalTrials.gov
SAS115359, a Safety and Efficacy Study of Inhaled Fluticasone Propionate/Salmeterol Combination Versus Inhaled Fluticasone Propionate in the Treatment of Adolescent and Adult Subjects With Asthma
INTERVENTIONAL
Inicio: 18 de nov de 2011
ID: NCT01475721
Completado
Fase 2
ClinicalTrials.gov
A Double-blind, Placebo-controlled, Randomised, Parallel-group, Phase II, Multi-centre Study to Assess the Efficacy, Safety and Tolerability of 4 Twice Daily Doses and 2 Once Daily Doses of AZD1981 Given as Tablets During 12 Weeks in Asthmatic Patients
INTERVENTIONAL
Inicio: 1 de oct de 2010
ID: NCT01197794
Anterior
1
...
36
37
38
...
434
Siguiente
Filtros